June 7, 2016
Shionogi said on June 6 that the US FDA has accepted its application for naldemedine, a treatment for opioid-induced constipation (OIC), with a Prescription Drug User Fee Act (PDUFA) date set for March 23, 2017. The drug was filed in...read more